BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Phiri P, Engelthaler T, Carr H, Delanerolle G, Holmes C, Rathod S. Associated mortality risk of atypical antipsychotic medication in individuals with dementia. World J Psychiatry 2022; 12(2): 298-307 [PMID: 35317344 DOI: 10.5498/wjp.v12.i2.298]
URL: https://www.wjgnet.com/2220-3206/full/v12/i2/298.htm
Number Citing Articles
1
Shanquan Chen, Rudolf N. Cardinal, Kathryn Auckland, Stefan Gräf, John T. O’Brien, Benjamin R. Underwood. Risk Factors for Longer-Term Mortality in Discharged Patients with Dementia and SARS-CoV-2 Infection: A Matched Case-Control StudyJournal of Alzheimer's Disease 2023; 92(1): 295 doi: 10.3233/JAD-221093
2
Carlo Rossi, Nicole Campese, Carlo Colosimo. Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative reviewExpert Opinion on Pharmacotherapy 2023; 24(13): 1415 doi: 10.1080/14656566.2023.2224501
3
亭 朱. Progress in the Treatment of Alzheimer’s DiseaseAdvances in Clinical Medicine 2023; 13(03): 3049 doi: 10.12677/ACM.2023.133433
4
Zhi-Peng Li, Yu-Shun You, Jun-Dong Wang, Lian-Ping He. Underlying disease may increase mortality risk in users of atypical antipsychoticsWorld Journal of Psychiatry 2022; 12(8): 1112-1114 doi: 10.5498/wjp.v12.i8.1112